India Hydroxychloroquine
- All
- News
- Videos
-
Top Medical Body Drops Ivermectin, Hydroxychloroquine From Covid Treatment
Indian Council of Medical Research (ICMR)-COVID-19 National Task Force Joint Monitoring Group dropped the usage of Ivermectin and Hydroxychloroquine (HCQ) drugs from revised clinical guidelines for the management of adult COVID-19 patients.
-
Ivermectin, HCQ Dropped From One Covid Treatment List, Kept On Another
The Union health ministry has issued revised guidelines for management of Covid-infected patients, dropping many sought-after drugs like ivermectin, hydroxychloroquine and anti-viral Favipiravir from Covid treatment.
-
India Sending Humanitarian Assistance To Drought-Hit Madagascar: S Jaishankar
India is sending a consignment of 1,000 metric tonnes of rice and 100,000 hydroxychloroquine tablets to Madagascar in response to the east African country's appeal for assistance to deal with a humanitarian crisis triggered by a severe drought, the Ministry of External Affairs said on Monday.
-
Re-Purposed Hydroxychloroquine Being Used For Mild, Moderate Covid Cases: Harsh Vardhan
Re-purposed hydroxychloroquine is being used for mild but high risk and moderate COVID-19 cases, Union Health Minister Harsh Vardhan said in Rajya Sabha on Tuesday.
-
Centre Allocates 4.24 Crore Hydroxychloroquine Tablets To States
The Union health ministry made the biggest allocation of hydroxychloroquine (HCQ) tablets since the beginning of the COVID-19 pandemic in India by distributing 4.24 crore medicines to the states and Union Territories.
-
HCQ, Chloroquine Do Not Show Antiviral Effect Against Coronavirus, Studies Reveal
Chloroquine and hydroxychloroquine, either alone or in combination with the antibiotic azithromycin, do not show any notable antiviral effect against infections with the novel coronavirus in macaques or human lung cells, according to two new studies in the journal Nature.
-
Centre Lifts Export Ban On Anti-Malarial Drug Hydroxychloroquine
The government on Thursday lifted the export ban on anti-malarial drug hydroxychloroquine with immediate effect.
-
Health Ministry Okays Anti-Malarial Drug HCQ For Early Course Of COVID-19
The Union Health Ministry has recommended use of anti-viral drug remdesivir under emergency use authorization, off-label application of immunomodulator tocilizumab and convalescent plasma therapy for treating COVID-19 patients in moderate stage of criticality.
-
India Lifts Export Ban On Trump-Touted COVID-19 Drug Hydroxychloroquine
India has lifted an export ban on hydroxychloroquine, the anti-malarial drug touted by US President Donald Trump as a potential "game changer" in the fight against the COVID-19 pandemic, a minister said late on Wednesday.
-
Over 9,000 Coronavirus Cases In India In A Single Day For First Time
India's tally of coronavirus cases has cross 2.16 lakh after a record number of 9,304 people tested positive for the deadly virus infection in the last 24 hours. The total cases in the country stood at 2,16,919, including 6,075 deaths, Union Health Ministry data shows. As India and other nations fight the pandemic, the World Health Organization (WH...
-
Donald Trump Feeling "Absolutely Great" After Taking Hydroxychloroquine: White House
US President Donald Trump is feeling "absolutely great" after taking a two-week dose of antimalarial drug hydroxychloroquine and will take it again if he thinks he is exposed to the coronavirus, a top White House official has said.
-
Benefits Of Hydroxychroloquine Outweighs Its Risks: Niti Aayog Member
As per the current available data, benefits of anti-malarial drug Hydroxychroloquine (HCQ) "outweighs" the risks, if any, Niti Aayog member VK Paul said on Thursday, asserting it should be used as per guidelines and recommendations made by the scientific community.
-
HCQ Should Be Used For COVID-19, Says Indian Medical Body After WHO Alert
Indian researchers have not found any major side-effects of hydroxychloroquine or HCQ and its use should be continued in preventive treatment for COVID-19, the Indian Council of Medical Research (ICMR) said on Tuesday.
-
Top Medical Body ICMR Issues Revised Advisory On Use Of Anti-Malarial Drug Hydroxychloroquine
A revised government advisory has recommended use of hydroxychloroquine as a preventive medication for asymptomatic healthcare workers working in non-COVID-19 hospitals, frontline staff on surveillance duty in containment zones and paramilitary/police personnel involved in coronavirus infection related activities.
-
Centre Expands Hydroxychloroquine As Prophylactic For Healthcare, Other Frontline Workers
After some promising results on the efficacy of prophylactic use of Hydroxychloroquine (HCQ) against COVID-19 infection, the Central government has expanded the use of the medicine as prophylaxis to healthcare and other frontline workers deployed in non-COVID and COVID area.
-
Top Medical Body Drops Ivermectin, Hydroxychloroquine From Covid Treatment
Indian Council of Medical Research (ICMR)-COVID-19 National Task Force Joint Monitoring Group dropped the usage of Ivermectin and Hydroxychloroquine (HCQ) drugs from revised clinical guidelines for the management of adult COVID-19 patients.
-
Ivermectin, HCQ Dropped From One Covid Treatment List, Kept On Another
The Union health ministry has issued revised guidelines for management of Covid-infected patients, dropping many sought-after drugs like ivermectin, hydroxychloroquine and anti-viral Favipiravir from Covid treatment.
-
India Sending Humanitarian Assistance To Drought-Hit Madagascar: S Jaishankar
India is sending a consignment of 1,000 metric tonnes of rice and 100,000 hydroxychloroquine tablets to Madagascar in response to the east African country's appeal for assistance to deal with a humanitarian crisis triggered by a severe drought, the Ministry of External Affairs said on Monday.
-
Re-Purposed Hydroxychloroquine Being Used For Mild, Moderate Covid Cases: Harsh Vardhan
Re-purposed hydroxychloroquine is being used for mild but high risk and moderate COVID-19 cases, Union Health Minister Harsh Vardhan said in Rajya Sabha on Tuesday.
-
Centre Allocates 4.24 Crore Hydroxychloroquine Tablets To States
The Union health ministry made the biggest allocation of hydroxychloroquine (HCQ) tablets since the beginning of the COVID-19 pandemic in India by distributing 4.24 crore medicines to the states and Union Territories.
-
HCQ, Chloroquine Do Not Show Antiviral Effect Against Coronavirus, Studies Reveal
Chloroquine and hydroxychloroquine, either alone or in combination with the antibiotic azithromycin, do not show any notable antiviral effect against infections with the novel coronavirus in macaques or human lung cells, according to two new studies in the journal Nature.
-
Centre Lifts Export Ban On Anti-Malarial Drug Hydroxychloroquine
The government on Thursday lifted the export ban on anti-malarial drug hydroxychloroquine with immediate effect.
-
Health Ministry Okays Anti-Malarial Drug HCQ For Early Course Of COVID-19
The Union Health Ministry has recommended use of anti-viral drug remdesivir under emergency use authorization, off-label application of immunomodulator tocilizumab and convalescent plasma therapy for treating COVID-19 patients in moderate stage of criticality.
-
India Lifts Export Ban On Trump-Touted COVID-19 Drug Hydroxychloroquine
India has lifted an export ban on hydroxychloroquine, the anti-malarial drug touted by US President Donald Trump as a potential "game changer" in the fight against the COVID-19 pandemic, a minister said late on Wednesday.
-
Over 9,000 Coronavirus Cases In India In A Single Day For First Time
India's tally of coronavirus cases has cross 2.16 lakh after a record number of 9,304 people tested positive for the deadly virus infection in the last 24 hours. The total cases in the country stood at 2,16,919, including 6,075 deaths, Union Health Ministry data shows. As India and other nations fight the pandemic, the World Health Organization (WH...
-
Donald Trump Feeling "Absolutely Great" After Taking Hydroxychloroquine: White House
US President Donald Trump is feeling "absolutely great" after taking a two-week dose of antimalarial drug hydroxychloroquine and will take it again if he thinks he is exposed to the coronavirus, a top White House official has said.
-
Benefits Of Hydroxychroloquine Outweighs Its Risks: Niti Aayog Member
As per the current available data, benefits of anti-malarial drug Hydroxychroloquine (HCQ) "outweighs" the risks, if any, Niti Aayog member VK Paul said on Thursday, asserting it should be used as per guidelines and recommendations made by the scientific community.
-
HCQ Should Be Used For COVID-19, Says Indian Medical Body After WHO Alert
Indian researchers have not found any major side-effects of hydroxychloroquine or HCQ and its use should be continued in preventive treatment for COVID-19, the Indian Council of Medical Research (ICMR) said on Tuesday.
-
Top Medical Body ICMR Issues Revised Advisory On Use Of Anti-Malarial Drug Hydroxychloroquine
A revised government advisory has recommended use of hydroxychloroquine as a preventive medication for asymptomatic healthcare workers working in non-COVID-19 hospitals, frontline staff on surveillance duty in containment zones and paramilitary/police personnel involved in coronavirus infection related activities.
-
Centre Expands Hydroxychloroquine As Prophylactic For Healthcare, Other Frontline Workers
After some promising results on the efficacy of prophylactic use of Hydroxychloroquine (HCQ) against COVID-19 infection, the Central government has expanded the use of the medicine as prophylaxis to healthcare and other frontline workers deployed in non-COVID and COVID area.
